Anti-malignin antibody
Anti-malignin antibody (AMA) is a type of antibody that is found in the blood of some people who have cancer. It is used as a biomarker to detect the presence of cancer in the body. The presence of AMA in the blood can be detected through a blood test.
Overview[edit]
Anti-malignin antibody is a protein that the body's immune system produces in response to the presence of malignant cells. It is one of many types of antibodies that the immune system produces to fight off foreign substances in the body.
Detection[edit]
The presence of AMA in the blood can be detected through a blood test. This test is often used in conjunction with other tests to diagnose cancer. However, the presence of AMA in the blood does not necessarily mean that a person has cancer. Other conditions can also cause the immune system to produce AMA.
Use in Cancer Diagnosis[edit]
While the presence of AMA in the blood can be an indication of cancer, it is not a definitive diagnostic tool. Other tests, such as biopsy, imaging tests, and laboratory tests, are also necessary to confirm a diagnosis of cancer.
Limitations[edit]
The use of AMA as a biomarker for cancer has its limitations. Not all types of cancer cause the immune system to produce AMA. Furthermore, the presence of AMA in the blood can also be caused by other conditions, such as inflammation or infection. Therefore, a positive AMA test does not necessarily mean that a person has cancer.
See Also[edit]
This WikiMD article can only be edited by registered and verified editors. You can log in or register.
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
